• A case of ovarian carcinosarcoma with a germline pathogenic variant of BRCA2 involving a perforated appendix with an abscess
• A mural nodule of anaplastic carcinoma with sarcomatoid differentiation in a background of ovarian borderline mucinous cystadenoma
• A transcriptome-Based Deep Neural Network Classifier for Identifying the Site of Origin in Mucinous Cancer
• APOBEC3C is a novel target for the immune treatment of lower-grade gliomas
• ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
• Carcinosarcoma of the ovary: a case report and literature review
• Carcinosarcoma of the uterus, derived from subserous cystic adenomyosis, presenting as an acute abdomen: A case report and review of the literature
• Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types
• Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway
• Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
• Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma
• Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report
• Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility
• Comprehensive analysis of the expression and prognosis for APOE in malignancies: A pan-cancer analysis
• Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint
• Conservative management of burst adbomen after interval cytoreduction surgery of ovarian carcinosarcoma
• Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience
• Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature
• Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors
• Detection of FOXL2 C134W Mutation Status by a Novel BaseScope-ISH Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors
• DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis
• Disparity in the era of personalized medicine for epithelial ovarian cancer
• Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
• Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
• Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia
• Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia
• Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma
• Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26)
• Endometrial carcinoma with diffuse melanocytic differentiation: Clinicopathological and molecular analysis of a case with literature review and focus on differential diagnosis
• Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
• Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases
• FIGO staging of endometrial cancer: 2023
• FIGO staging of endometrial cancer: 2023
• Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma
• Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases
• Frontiers of Ovarian Carcinosarcoma
• Genetic Analysis and Combined Therapy of Surgery and Chemotherapy for the Progression-Free Survival of a Patient with Ovarian Carcinosarcoma: A Case Report and Literature Review
• Genome-wide spatial expression profiling in formalin-fixed tissues
• Genomic and Molecular Characteristics of Ovarian Carcinosarcoma
• Germline drivers of gynecologic carcinosarcomas
• Gynecological carcinosarcomas: Overview and future perspectives
• Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers
• Identifies microtubule-binding protein <em>CSPP1</em> as a novel cancer biomarker associated with ferroptosis and tumor microenvironment
• Impact of lymph node staging in presumed early-stage ovarian carcinoma
• Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea
• Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine Sarcomas
• Low-level expression of human Epidermal growth Factor Receptor-2 (HER2) in High-Grade Mullerian Tumors: Implications for therapy decision making
• Magnetic resonance imaging for the diagnosis of malignant mixed Mullerian tumor of ovary: Two case reports
• Management of a rare ovarian carcinosarcoma: A case report and literature review
• Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas
• Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression
• Metastatic ovarian carcinosarcoma in a patient undergoing in-vitro fertilization: A case report
• Molecular characteristics and clinical behaviour of epithelial ovarian cancers
• Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations
• Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment
• Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
• Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis
• New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer-A Systematic Review
• Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma
• Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor
• Ovarian Carcinosarcoma and Response to Immunotherapy
• Ovarian Carcinosarcoma Associated with Cowden Syndrome-A Case Report
• Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
• Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes
• Ovarian Carcinosarcoma Mimicking Symptoms of Recurrent Diverticulitis: A Case Report
• Ovarian Carcinosarcoma: Rare Histology Which Never Fails to be Aggressive
• Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma Component: A Case Report
• Ovarian teratoid carcinosarcoma with a <em>PIK3CA</em> mutation: a case report and review of the literature
• Ovarian teratoid carcinosarcoma with a PIK3CA mutation: a case report and review of the literature
• PRAME Expression in Cancer. A Systematic Immunohistochemical Study of &gt;5800 Epithelial and Nonepithelial Tumors
• PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian Carcinosarcomas
• Preliminary study of confocal laser endomicroscopy for in vitro specimens of the endometrium
• Prevalence, risk factors, prognostic factors and nomogram for distant metastasis in ovarian carcinosarcoma: A SEER population-based analysis
• Primary ovarian malignant mixed Mullerian tumor: a rare case report
• Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline <em>BRCA2</em> Pathogenic Variant: Case Report
• Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report
• Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis
• Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience
• Rare non-serous fallopian tube cancers: institutional experience and literature review
• Rate of Vaginal Cuff Dehiscence When Using Vicryl (Poliglactyn 910) Compared to PDS (Polydioxanone) for Vaginal Cuff Closure in Laparoscopic Hysterectomy
• Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
• Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report
• Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study
• Sigmoido-ovarian fistula complicating ovarian carcinosarcoma: a case report
• Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma
• STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumours
• Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report
• Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case
• Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human Cancers
• Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers
• Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers
• The BRCAness Landscape of Cancer
• The peritoneal cancer index as a predictor of complete cytoreduction at primary and interval cytoreductive surgery in advanced ovarian cancer
• The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma
• Top advances of the year: Ovarian cancer
• Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression
• Treatment of HRD-positive ovarian carcinosarcoma: A case report and literature review
• Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database
• Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin
• Unveiling the mille-feuille sign: a key to diagnosing ovarian carcinosarcoma in addition to ovarian metastasis from colorectal carcinoma on MRI